PRESS RELEASE published on 04/07/2026 at 11:05, 5 months 3 days ago Virbac : Déclaration d'actions et de droits de votes 03/2026 Déclaration d'actions et de droits de vote pour Virbac, société cotée sur Euronext Paris. Détails sur le nombre total d'actions et de droits de vote. Contact : finances@virbac.com Euronext Paris Déclaration Droits De Vote Santé Animale VIRBAC
PRESS RELEASE published on 03/17/2026 at 19:00, 5 months 24 days ago Virbac: Communiqué de mise à disposition des comptes consolidés au 31 décembre 2025
PRESS RELEASE published on 03/17/2026 at 19:00, 5 months 24 days ago Virbac: Public Release of the Year-End Consolidated Accounts at 31 December 2025
BRIEF published on 12/16/2025 at 09:58, 8 months 25 days ago Virbac acquiert Thyronorm pour lutter contre l'hyperthyroïdie féline Santé Animale Médecine Vétérinaire VIRBAC Hyperthyroïdie Féline Thyronorm
BRIEF published on 12/16/2025 at 09:58, 8 months 25 days ago Virbac Acquires Thyronorm to Combat Feline Hyperthyroidism Veterinary Medicine Animal Health Feline Hyperthyroidism VIRBAC Thyronorm
BRIEF published on 12/16/2025 at 09:58, 8 months 25 days ago Virbac acquiert Thyronorm pour le traitement de l'hyperthyroïdie féline Acquisition Santé Animale VIRBAC Hyperthyroïdie Féline Thyronorm
BRIEF published on 12/16/2025 at 09:58, 8 months 25 days ago Virbac acquires Thyronorm for the treatment of feline hyperthyroidism Acquisition Animal Health Feline Hyperthyroidism VIRBAC Thyronorm
PRESS RELEASE published on 12/16/2025 at 09:53, 8 months 25 days ago VIRBAC: Feline Hyperthyroidism: Virbac acquires Thyronorm Virbac acquires innovative drug Thyronorm from Norbrook to stabilize feline hyperthyroidism, expanding distribution in key markets and enhancing senior cats' quality of life Acquisition Feline Hyperthyroidism VIRBAC Thyronorm Senior Cats
PRESS RELEASE published on 12/16/2025 at 09:53, 8 months 25 days ago VIRBAC: Hyperthyroïdie féline : Virbac acquiert Thyronorm Virbac acquiert Thyronorm pour traiter l'hyperthyroïdie féline, améliorant la qualité de vie des chats âgés. L'acquisition renforce le portefeuille produits de Virbac Acquisition VIRBAC Hyperthyroïdie Féline Thyronorm Chats Âgés
BRIEF published on 11/07/2025 at 15:44, 10 months 3 days ago Virbac : Mise à jour sur les actions et droits de vote Euronext Paris Droits De Vote Actions Transparence VIRBAC
Published on 09/10/2026 at 22:25, 4 hours 48 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 11 hours 53 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 12 hours 13 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/10/2026 at 14:37, 12 hours 36 minutes ago Worksport (NASDAQ:WKSP) Invites Shareholders to September 15 CEO Town Hall
Published on 09/11/2026 at 00:05, 3 hours 7 minutes ago Club Offers for Travel Enthusiasts in Germany
Published on 09/11/2026 at 00:01, 3 hours 12 minutes ago Club Offers for Travel Enthusiasts in Germany
Published on 09/10/2026 at 22:39, 4 hours 33 minutes ago EQS-Adhoc: Notice by Rumble Deutschland AG regarding an upcoming squeeze-out under German Stock Corporation Law
Published on 09/10/2026 at 22:10, 5 hours 2 minutes ago flatexDEGIRO with changes to the Supervisory Board
Published on 09/10/2026 at 22:07, 5 hours 6 minutes ago EQS-Adhoc: flatexDEGIRO SE: Changes to the Supervisory Board
Published on 09/10/2026 at 19:30, 7 hours 43 minutes ago Availability of the 2026 Interim Financial Report
Published on 09/10/2026 at 19:30, 7 hours 43 minutes ago Mise à disposition du Rapport Financier Semestriel 2026
Published on 09/10/2026 at 18:10, 9 hours 3 minutes ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 août 2026
Published on 09/10/2026 at 17:45, 9 hours 28 minutes ago COGRA : RÉSULTATS ANNUELS 2025/26 - Retour à la croissance rentable et structure financière renforcée
Published on 09/10/2026 at 17:42, 9 hours 30 minutes ago Déclaration d'actions et de droits de vote au 31.08.2026
